Wednesday, April 25, 2018

bio technology

bio technology
The ticker and logo for General Electric Co. is displayed on a screen at the post where it's traded on the floor of the NYSE

GE Rides Gene Therapy Wave with Ready-Made Viral Drug Factories

By Ben Hirschler LONDON (Reuters) General Electric is raising its bet on biotechnology with the launch of prefabricated manufacturing units for producing virus-based gene and cell...
Swiss pharmaceutical group Lonza's world’s largest dedicated cell and gene therapy facility in Houston

Lonza’s Virus Factory Shows Gene Therapy’s Texas-Sized Promise

By John Miller ZURICH (Reuters) Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative...
Novo Nordisk buys blood drug licence to boost anaemic biopharma business

Novo Nordisk Buys Blood Drug Licence to Boost Anemic Biopharma Business

COPENHAGEN (Reuters) Danish drugmaker Novo Nordisk has secured the global licence for U.S. biotech company EpiDestiny's sickle cell disease (SCD) program in a bid...
Orchid stands on a table at the entrance to Loxo Oncology headquarters in Stamford

High-Flying Biotech Loxo Tempers Bullish View for Cancer Drug

By Bill Berkrot STAMFORD, Connecticut (Reuters) In record time, Loxo Oncology developed a novel drug for a wide variety of tumors that share a rare mutation....
Fujifilm Holdings' logos are pictured ahead of its news conference in Tokyo

Fujifilm to Buy Two Biotech Units from JXTG for $800 Million

TOKYO (Reuters) Fujifilm Holdings said it would buy two biotechnology units of Japan's JXTG Holdings Inc for about $800 million, as it looks to boost...
An electronic patients chart is shown on the wall to a hospital room in San Diego, California

In Broad Healthcare Bets, Small Stocks Favored over Large

By Lewis Krauskopf NEW YORK (Reuters) When it comes to investing in the U.S. healthcare sector, it has paid off big to bet on smaller stocks So...
banner